Protective Role of Humanin on Bortezomib-Induced Bone Growth Impairment in Anticancer Treatment

Bortezomib with chemotherapy is highly active in advanced B-precursor acute lymphoblastic leukemia: Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study

(2012) Y. H. Messinger et al.   BLOOD

Sorafenib inhibits endogenous and IL-6/S1P induced JAK2-STAT3 signaling in human neuroblastoma, associated with growth suppression and apoptosis

(2012) Fan Yang et al.   CANCER BIOLOGY & THERAPY

Starvation, detoxification, and multidrug resistance in cancer therapy

(2012) Changhan Lee et al.   DRUG RESISTANCE UPDATES

A phase I trial of vorinostat and bortezomib in children with refractory or recurrent solid tumors: A Children's Oncology Group phase I consortium study (ADVL0916)

(2012) Jodi A. Muscal et al.   PEDIATRIC BLOOD & CANCER

Bortezomib Is Cytotoxic to the Human Growth Plate and Permanently Impairs Bone Growth in Young Mice

(2012) Emma Eriksson et al.   PLoS One

Humanin preserves endothelial function and prevents atherosclerotic plaque progression in hypercholesterolemic ApoE deficient mice

(2011) Yun K. Oh et al.   ATHEROSCLEROSIS

Phenotype-based drug screening in primary ovarian carcinoma cultures identifies intracellular iron depletion as a promising strategy for cancer treatment

(2011) Joachim Gullbo et al.   BIOCHEMICAL PHARMACOLOGY

Effects of small molecule inhibitors of PI3K/Akt/mTOR signaling on neuroblastoma growth in vitro and in vivo

(2011) Lova Segerström et al.   INTERNATIONAL JOURNAL OF CANCER

Outcomes for Children and Adolescents With Cancer: Challenges for the Twenty-First Century

(2010) Malcolm A. Smith et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase I study of bortezomib combined with chemotherapy in children with relapsed childhood acute lymphoblastic leukemia (ALL): A report from the therapeutic advances in childhood leukemia (TACL) consortium

(2010) Yoav Messinger et al.   PEDIATRIC BLOOD & CANCER

Embryonal neural tumours and cell death

(2009) John Inge Johnsen et al.   APOPTOSIS

Opposing Roles of Insulin-Like Growth Factor Binding Protein 3 and Humanin in the Regulation of Testicular Germ Cell Apoptosis

(2009) YanHe Lue et al.   ENDOCRINOLOGY

Docosahexaenoic acid metabolome in neural tumors: identification of cytotoxic intermediates

(2009) Helena Gleissman et al.   FASEB JOURNAL

The neurosurvival factor Humanin inhibits β-cell apoptosis via signal transducer and activator of transcription 3 activation and delays and ameliorates diabetes in nonobese diabetic mice

(2009) Phuong T. Hoang et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Humanin Inhibits Neuronal Cell Death by Interacting with a Cytokine Receptor Complex or Complexes Involving CNTF Receptor α/WSX-1/gp130

(2009) Yuichi Hashimoto et al.   MOLECULAR BIOLOGY OF THE CELL

Bortezomib reverses a post-translational mechanism of tumorigenesis forpatched1haploinsufficiency in medulloblastoma

(2009) Eri Taniguchi et al.   PEDIATRIC BLOOD & CANCER

Humanin: A Novel Central Regulator of Peripheral Insulin Action

(2009) Radhika H. Muzumdar et al.   PLoS One

Microsomal prostaglandin E synthase 1 determines tumor growth in vivo of prostate and lung cancer cells

(2009) H. Hanaka et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Phase I and pharmacokinetic study of karenitecin in patients with recurrent malignant gliomas

(2008) Stuart A. Grossman et al.   NEURO-ONCOLOGY

RETRACTED: S14G-Humanin ameliorates Aβ25-35-induced behavioral deficits by reducing neuroinflammatory responses and apoptosis in mice

(2008) Jianting Miao et al.   NEUROPEPTIDES

Dose translation from animal to human studies revisited

(2007) Shannon Reagan-Shaw et al.   FASEB JOURNAL

Endochondral ossification: How cartilage is converted into bone in the developing skeleton

(2007) E.J. Mackie et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Initial testing (stage 1) of the proteasome inhibitor bortezomib by the pediatric preclinical testing program

(2007) Peter J. Houghton et al.   PEDIATRIC BLOOD & CANCER